Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Controls in Experiments

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

Blind Procedures

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...

What is an Experiment?

What is an Experiment?

An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Smart use of AI in healthcare: the growing role of AI literacy].

Nederlands tijdschrift voor geneeskunde·2026

Same author

Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands.

Health research policy and systems·2020

Same author

[The 'interesting case' and patient privacy: handling patient data in medical education].

Nederlands tijdschrift voor geneeskunde·2015

Same author

[Compare new therapies with old, not with a placebo: a plea for revision of the Declaration of Helsinki].

Nederlands tijdschrift voor geneeskunde·2013

Same author

[Neckpain: additional investigations only when there is an indication--treatment is rarely necessary].

Nederlands tijdschrift voor geneeskunde·2013

Same author

[Registration of ethnicity allowed with conditions].

Nederlands tijdschrift voor geneeskunde·2009

Search research articles

Related Experiment Video

Updated: May 18, 2026

Social Threat-Safety Test Uncovers Psychosocial Stress-Related Phenotypes

Social Threat-Safety Test Uncovers Psychosocial Stress-Related Phenotypes

Published on: December 15, 2023

[Vigilance in experimental treatment].

M C Corrette Ploem¹, M Rien Vermeulen

¹Afd. Sociale Geneeskunde, Academisch Medisch Centrum, Amsterdam, the Netherlands. m.c.ploem@amc.uva.nl

Nederlands Tijdschrift Voor Geneeskunde

|October 4, 2012

Summary

Experimental treatments, when standard care fails, require more than just patient consent in the Netherlands. Enhanced transparency through registration and reporting of effects and side effects is crucial for patient safety and ethical medical practice.

Area of Science:

Medical Ethics
Health Policy

Context:

Experimental treatments are distinct from medical research in the Netherlands.
Current Dutch law mandates patient explanation and consent for experimental treatments.

Purpose:

To evaluate the adequacy of current Dutch legal requirements for experimental treatments.
To propose enhanced transparency measures for experimental treatments.

Summary:

Dutch law requires doctors to explain and obtain consent for experimental treatments, documenting them in medical records.
The study argues current regulations are insufficient due to the inherent risks of experimental therapies.
Two additional conditions are proposed: mandatory registration of experimental treatments and reporting of their effects and side effects.

More Related Videos

Operant Procedures for Assessing Behavioral Flexibility in Rats

Operant Procedures for Assessing Behavioral Flexibility in Rats

Published on: February 15, 2015

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Published on: July 11, 2025

Related Experiment Videos

Last Updated: May 18, 2026

Social Threat-Safety Test Uncovers Psychosocial Stress-Related Phenotypes

Social Threat-Safety Test Uncovers Psychosocial Stress-Related Phenotypes

Published on: December 15, 2023

Operant Procedures for Assessing Behavioral Flexibility in Rats

Operant Procedures for Assessing Behavioral Flexibility in Rats

Published on: February 15, 2015

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Published on: July 11, 2025

Impact:

Increased transparency in experimental treatments can improve patient safety and ethical oversight.
Recommendations may inform future Dutch healthcare policy and regulatory frameworks for experimental therapies.
Shared data on treatment outcomes can advance medical knowledge and guide clinical decision-making.